Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hua, J.
Right arrow Articles by Nagaoka, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hua, J.
Right arrow Articles by Nagaoka, I.
(Journal of Leukocyte Biology. 2002;71:632-640.)
© 2002 by Society for Leukocyte Biology

Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils

Jian Hua*, Koji Sakamoto{dagger} and Isao Nagaoka*

* Department of Biochemistry, Juntendo University, School of Medicine, Tokyo, Japan; and
{dagger} Koyo Chemical Co., Ltd., Tokyo, Japan

Correspondence: Isao Nagaoka, Department of Biochemistry, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. E-mail: nagaokai{at}med.juntendo.ac.jp

Glucosamine, an amino monosaccharide naturally occurring in the connective and cartilage tissues, contributes to maintaining the strength, flexibility, and elasticity of these tissues. In recent years, glucosamine has been used widely to treat osteoarthritis in humans and animal models. Neutrophils, which usually function as the primary defenders in bacterial infections, are also implicated in the destructive, inflammatory responses in arthritis. In this study, we have evaluated the effects of glucosamine on neutrophil functions using human peripheral blood neutrophils. Glucosamine (0.01–1 mM) dose-dependently suppressed the superoxide anion generation induced by formyl-Met-Leu-Phe (fMLP) or complement-opsonized zymosan and inhibited the phagocytosis of complement-opsonized zymosan or IgG-opsonized latex particles. Furthermore, glucosamine inhibited the release of granule enzyme lysozyme from phagocytosing neutrophils and suppressed neutrophil chemotaxis toward zymosan-activated serum. In addition, glucosamine inhibited fMLP-induced up-regulation of CD11b significantly, polymerization of actin, and phosphorylation of p38 mitogen-activated protein kinase (MAPK). In contrast, N-acetyl-glucosamine, an analogue of glucosamine, did not affect these neutrophil functions (superoxide generation, phagocytosis, granule enzyme release, chemotaxis, CD11b expression, actin polymerization, and p38 MAPK phosphorylation) at the concentrations examined (1–10 mM). Together these observations likely suggest that glucosamine suppresses the neutrophil functions, thereby possibly exhibiting anti-inflammatory actions in arthritis.

Key Words: superoxide • phagocytosis • chemotaxis • F-actin • p38 mitogen-activated protein kinase




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Xing, W. Feng, L. G. Not, A. P. Miller, Y. Zhang, Y.-F. Chen, E. Majid-Hassan, J. C. Chatham, and S. Oparil
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H335 - H342.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Nakayama, F. Yoshizaki, A. Prinetti, S. Sonnino, L. Mauri, K. Takamori, H. Ogawa, and K. Iwabuchi
Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms
J. Leukoc. Biol., March 1, 2008; 83(3): 728 - 741.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B A Biggee, C M Blinn, T E McAlindon, M Nuite, and J E Silbert
Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness
Ann Rheum Dis, February 1, 2006; 65(2): 222 - 226.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Chou, N. Vergnolle, J. J. McDougall, J. L. Wallace, S. Marty, V. Teskey, and A. G. Buret
Effects of Chondroitin and Glucosamine Sulfate in a Dietary Bar Formulation on Inflammation, Interleukin-1{beta}, Matrix Metalloprotease-9, and Cartilage Damage in Arthritis
Experimental Biology and Medicine, April 1, 2005; 230(4): 255 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Gomez-Cambronero, J. Horn, C. C. Paul, and M. A. Baumann
Granulocyte-Macrophage Colony-Stimulating Factor Is a Chemoattractant Cytokine for Human Neutrophils: Involvement of the Ribosomal p70 S6 Kinase Signaling Pathway
J. Immunol., December 15, 2003; 171(12): 6846 - 6855.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Is glucosamine worth taking for osteoarthritis?
DTB, November 1, 2002; 40(11): 81 - 83.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Leukocyte Biology.